雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Recurrence of age-related macular degeneration in cases following switching to aflibercept therapy Jinhee Lee 1 , Keiko Azuma 1 , Shun Ogawa 1,2 , Hiroko Inui 1 , Aya Matsuda 1,3 , Tatsuya Inoue 1 , Ryo Obata 1 1Department of Ophthalmology, The University of Tokyo Hospital 2Department of Ophthalmology, Tokyo Metropolitan Police Hospital 3Department of Ophthalmology, Toranomon Hospital pp.1563-1567
Published Date 2017/10/15
DOI https://doi.org/10.11477/mf.1410212438
  • Abstract
  • Look Inside
  • Reference

Abstract Purpose:To report 29 cases who were switched to aflibercept therapy for exudative age-related macular degeneration(AMD)and who showed stabilization following treatment at 12-week interval by treat-and-extend(TAE)method.

Cases and Method:This study was made on 29 eyes of 29 cases of AMD. They were chosen out of 66 eyes of 66 cases who showed resistance to ranibizumab and were switched to aflibercept and who needed aflibercept at a 12-week-interval by TAE method. These 29 cases were evaluated regarding background factors, rate of recurrence, and central retinal thickness.

Results:Ten cases showed recurrence after switching to aflibercept. Recurrence was independent of background factors or visual acuity before recurrence. Cases with recurrence showed greater value of central retinal thickness just before extending the interval of treatment to 12 weeks.

Conclusion:In cases of AMD treated by aflibercept by TAE method, increased central retinal thickness may serve as a predictive factor for recurrence before extending the interval to 12 weeks.


Copyright © 2017, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有